Scientists have discovered that a key protein may be the secret to treating prostate cancer patients with ‘miracle’ immunotherapy drugs. Clinical trials have now begun – with the goal of unleashing cancer-killing white blood cells to attack the tumour. But, so far, they have failed to work against prostate cancer and scientists have not been able to work out why. Researcher Professor Johann de Bono said: ‘There’s a lot of evidence that prostate cancer causes what we call immune tolerance – that the cancer suppresses the body from attacking it with its immune cells. Prostate cancer is the most common cancer in men – with 48,500 cases a year and almost 12,000 needless deaths.
Source: Daily Mail May 08, 2021 00:22 UTC